Literature DB >> 26693636

Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-α therapy in psoriatic arthritis.

Yuki Honda1, Atsushi Otsuka1, Gyohei Egawa1, Yutaka Inoue2, Akira Kuzuya2, Ryosuke Takahashi2, Yoshiki Miyachi1, Kenji Kabashima1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26693636     DOI: 10.1684/ejd.2015.2558

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  5 in total

Review 1.  Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review.

Authors:  Marko Barešić; Mirna Reihl Crnogaj; Ivana Zadro; Branimir Anić
Journal:  Rheumatol Int       Date:  2021-09-23       Impact factor: 2.631

2.  Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.

Authors:  Amy Kunchok; Allen J Aksamit; John M Davis; Orhun H Kantarci; B Mark Keegan; Sean J Pittock; Brian G Weinshenker; Andrew McKeon
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

3.  Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?

Authors:  Laura Van Moortel; Kris Gevaert; Karolien De Bosscher
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-24       Impact factor: 5.555

4.  Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2).

Authors:  J L W Lambert; S Segaert; P D Ghislain; T Hillary; A Nikkels; F Willaert; J Lambert; R Speeckaert
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-08-13       Impact factor: 6.166

Review 5.  Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies.

Authors:  Tawfik Khoury; Yaron Ilan
Journal:  Front Immunol       Date:  2019-11-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.